Improvements in closed-loop processing and lower material costs could bring distributed manufacturing within reach. Hospitals still need to stand up production suites.
- An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs?
- Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty
- Is Your Supply Chain Ready For The End Of Class VI?
- Demonstrating Gene Therapy Potency: A Strategic Road Map
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- When Lyophilization Fails At Scale, First Scrutinize Your Formulation
- The 5 Shifts That Could Remake Lyophilization By 2040
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
When To Consider Material And Personnel Airlocks For Downflow Booths
Strategic use of airlocks in downflow booth design enhances pressure stability and containment. A risk-based approach ensures facility integration meets rigorous safety and compliance standards.
-
Engineering Challenges In Designing Pharmaceutical Isolators
Designing pharmaceutical barrier systems requires balancing strict cleanliness with practical engineering. Explore key factors for optimizing airflow and ergonomics.
-
Maximizing MSC Yield And Quality: A Comparative Media Study
Maximize mesenchymal stem cell (MSC) expansion with a simplified culture process. New data demonstrates a high-performance, xeno-free media that eliminates the need for coatings or media exchanges.
-
Tackling CGT Challenges: Stirred-Tank Bioreactors For R&D And Commercial Manufacturing
Scalability remains a key bottleneck in CGT manufacturing. See how optimized stirred-tank bioreactor systems accelerate translation from clinical to commercial production.
-
Comparing Nebulized Hydrogen Peroxide (NHP) And Vaporized Hydrogen Peroxide (VHP) For Isolator Decontamination
Compare Nebulized and Vaporized Hydrogen Peroxide efficacy, cycle times, and validation challenges inside pharmaceutical isolators to optimize your aseptic processing turnaround.
-
Best Practices For Oncolytic Virus Design, Development, Manufacturing
Oncolytic viruses have the potential to revolutionize standard cancer treatment, but their continued progress hinges on meeting a number of goals linked to safety, efficacy, and commercial scale-up.
-
Optimized Transient Transfection Platform: AAV Program From Gene To GMP
Achieve faster AAV gene therapy progress by adopting a unified platform for manufacturing. Accelerate your program to GMP readiness with up to 9x higher titers and robust, high-quality full capsid yields.
-
The Case For Modernizing Small-Volume Aseptic Processing
Tube welding and biosafety cabinets present significant costs and risks for small-volume aseptic processing. Modern single-use aseptic connectors offer a more efficient alternative.
-
Automating The Process Of Filling Media Into Bottles
Learn how a vaccine manufacturer using a wide range of containers for media and buffer filling was able to increase efficiency by 70% with an automated closed-system solution.
-
Comparative Evaluation Of NHP And VHP For Isolator Decontamination
Comparative evaluation reveals how optimizing hydrogen peroxide cycle parameters improves pharmaceutical isolator bio-decontamination efficiency while maintaining Annex 1 sterility compliance.
NEWSLETTER ARCHIVE
- 10.30.26 -- What Regionalized Filtration Networks Mean For Biopharma
- 10.30.26 -- Why Clinical Trial Design Matters For MSC Success
- 10.29.26 -- Expert Insights On Choosing The Right CGT Manufacturing Model
- 10.28.26 -- Accelerating Advanced Therapies: From Development To Manufacturing
- 10.28.26 -- The Manufacturing Reality Behind Advanced Therapy Commercial Scale
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- Inside Scaling Next-Gen MSCs Without Scaling Risk
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

